WithdrawnNCT01913912
Event Rate and Effects of Stimulants in ADHD
Medication studyAges 7–12Belgium
Understand this study
Who could participate?
Listed age limits: 7 years to 12 years.
- Listed locations
- Ghent and 1 more locationSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 2014
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- University Ghent
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Device, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Belgium
- Age range
- From 7 Years to 12 Years
- Official registry ID
- NCT01913912
- Official title
Show the full official title
Can Changing the Rate at Which Information is Presented Alter the Effects of Stimulants on ADHD Information Processing. Testing a Prediction of the State Regulation Deficit Model.
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ghent
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Ghent, a university.
Does this study involve medication?
Yes. The study involves medication, including LDX. and sugar pill.
Who can participate?
Listed age limits: 7 years to 12 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
Want to explore more studies?
Explore studiesRelated studies
A 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin® LA in the treatment of adult patients with childhood-onset ADHD
A 6-month, open-label extension to a 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin® LA in the treatment of adult patients with childhood-on...